LSL Pharma Group Inc. (TSXV:LSL)

Canada flag Canada · Delayed Price · Currency is CAD
0.375
0.00 (0.00%)
At close: Dec 5, 2025
-5.06%
Market Cap 45.46M
Revenue (ttm) 26.80M
Net Income (ttm) 2.78M
Shares Out 121.22M
EPS (ttm) 0.02
PE Ratio 16.53
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,789
Average Volume 68,582
Open 0.375
Previous Close 0.375
Day's Range 0.375 - 0.375
52-Week Range 0.290 - 0.530
Beta -0.29
RSI 53.23
Earnings Date Nov 25, 2025

About LSL Pharma Group

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. The company offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, and natural health products in liquid and semi-solid form for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada. [Read more]

Sector Healthcare
CEO Francois Roberge
Employees 186
Stock Exchange TSX Venture Exchange
Ticker Symbol LSL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.